• 2020 GAPNA Pharmacology Conference: Contemporary Pharmacology and Prescribing in Older AdultsJoin us at the 2020 GAPNA Pharmacology Conference:
    Contemporary Pharmacology and Prescribing in Older Adults

    April 14-18, 2020, Honolulu, HI.

    Earn up to 18 CNE hours.


    Find out more about it and REGISTER today!

  • W A N T E D   G A P N A   L E A D E R S!
    Call for Nominations!

    Have you ever considered stepping forward, accepting the challenge and volunteering for a position on the 2020-21 National Board of Directors? Register online NOW by March 22, 2020!

    Step Up - NOW is the Time! Register Here>

  • AwardNew for GAPNA members: MCM Education

    GAPNA has partnered with a MCM Education to offer an ongoing series of CNE programs available to GAPNA members. "Diagnosing and Managing Parkinson’s Disease in Older Adults," is the latest program offered.

    Parkinson’s disease (PD) is characterized by both motor and nonmotor symptoms. It is diagnosed based on the presence of two of four motor symptoms including rest tremor, bradykinesia, rigidity, and gait imbalance...

    Find out about it!

  • ConventionCALL FOR: Podium and Poster Abstracts

    For the 38th GAPNA Annual Conference
    at the Hyatt Regency
    New Orleans, LA, September 24-26, 2020

    GAPNA members are invited to submit an abstract about their innovative work, that should enrich the APRN's knowledge and/or enhance the care of an older adult. Deadline March 15, 2020.

    Find out more info and deadline dates

  • FREE CE for GAPNA MembersFREE continuing education credit is available for the following session:

    "Update in Chronic Kidney Disease Management and Prescribing"

    (session captured at the GAPNA 2018 Annual Conference)

    For January/February 2020 - Get Your Free CNE Now!

Medicare Part D Coverage Gap Reduces Antidepressant Use in the Elderly

The Medicare Part D prescription drug benefit includes a $265 deductible, an insured period during which the beneficiary pays 25%of drug costs from $265 to $2,400, and a coverage gap when the beneficiary pays 100 percent of drug costs until reaching the catastrophic limit of $3,850; then they pay 5%.

A new study found elderly Medicare patients with depression enrolled in stand-alone Part D plans in 2007 reduced their use of antidepressants during the Medicare Part D coverage gap.

In fact, a full gap in drug coverage resulted in a 12.1% reduction in antidepressant use, particularly for brand-name drugs.

For more info, see Zhang, Y. et al. (2012). Effects of Medicare Part D coverage gap on medication and medical treatment among elderly beneficiaries with depression. Archives of General Psychiatry, 69(7), 672-679.

Related Topic 1: 

GAPNA Newsletter Issue: